EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access

Assessing Pharmacists’ Use and Perception of AI Chatbots in Pharmacy Practice: Cross-Sectional Survey Study

Anly Li iD, Amy Heck Sheehan iD, Christopher Giuliano iD, Paul Dobry iD, Paul Walker iD, Jennifer Philips iD, Joseph Jordan iD

JMIR Medical Education · 2025

DOI: 10.2196/71767 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift JMIR Medical Education, 2025. Verfasst von Anly Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Regulatory Pharmaceutical Fellow in Drug Information, Purdue University College of Pharmacy, West Lafayette, IN, United States. Hauptthemen laut MEDLINE: Pharmacists, Artificial Intelligence. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The use of artificial intelligence (AI)–based large language model chatbots such as ChatGPT has become increasingly popular in many disciplines. However, concerns exist regarding ethics, legal considerations, accuracy, and reproducibility with its use in health care practice, education, and research.

Objective

This study aimed to assess current perceptions and use of AI chatbots in pharmacy practice from the perspective of pharmacist preceptors and determine factors that may influence the use of AI chatbots in practice.

Methods

A cross-sectional survey of pharmacy practice preceptors from Indiana, Illinois, and Michigan was conducted using the validated Technology Acceptance Model Edited to Assess ChatGPT Adoption (TAME-ChatGPT) survey tool to collect information regarding current use of AI chatbots and factors associated with use, including ease of use, perceived risk, technology or social influences, anxiety, and perceived usefulness.

Results

A total of 194 responses (194/1877, 10.34% response rate) were received. Approximately one-third (n=59, 30.4%) of respondents reported having used an AI chatbot, with 51.5% (n=100) indicating that they planned to start or would continue using chatbots in the future. In practice, common uses for AI chatbots included summarizing information (n=90, 46.4%), letter of recommendation writing (n=64, 32.9%), and obtaining disease state information (n=63, 32.5%). The 2 main constructs associated with the use of chatbots identified from the TAME-ChatGPT tool included perceived risk of using AI and attitude toward AI. Factors that predicted pharmacists’ current use of AI chatbots included positive attitude toward technology (odds ratio [OR] 3.64, 95% CI 2.08-6.36), coworker use of AI (OR 7.41, 95% CI 2.64-20.8), and working in academia (OR 5.62, 95% CI 1.30-24.23).

Conclusions

Most pharmacist respondents had not used an AI chatbot and were unlikely to make patient care decisions based on information from a chatbot. The TAME-ChatGPT survey is validated for assessing chatbot use and attitudes among pharmacists, and future studies using this survey tool can guide the implementation of chatbots into pharmacy practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacistsArtificial IntelligenceHumansCross-Sectional StudiesSurveys and QuestionnairesMaleFemaleAdultIndianaAttitude of Health PersonnelMiddle AgedIllinoisPerceptionMichiganPreceptorshipGenerative Artificial Intelligence

Stichwörter der Autor:innen

artificial intelligencechatbothealth care practicepharmacysurveytechnology

Autor:innen und Institutionen

  • Regulatory Pharmaceutical Fellow in Drug Information, Purdue University College of Pharmacy, West Lafayette, IN, United States.
  • Professor of Pharmacy Practice, Purdue University College of Pharmacy, West Lafayette, IN, United States.
  • Clinical Professor of Pharmacy Practice, Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences, Detroit, MI, United States.
  • Clinical Pharmacy Specialist, Drug Information, Detroit Receiving Hospital, Detroit, MI, United States.
  • Clinical Professor Emeritus, University of Michigan College of Pharmacy, Ann Arbor, MI, United States.
  • Clinical Professor of Pharmacy Practice, Director of Drug Information Group, University of Illinois Chicago College of Pharmacy, Chicago, IL, United States.

ORCID-Profile: Anly Li, Amy Heck Sheehan, Christopher Giuliano, Paul Dobry, Paul Walker, Jennifer Philips, Joseph Jordan

Zitieren

APA

Li, A., Sheehan, A. H., Giuliano, C., Dobry, P., Walker, P., Philips, J., & Jordan, J. (2025). Assessing Pharmacists’ Use and Perception of AI Chatbots in Pharmacy Practice: Cross-Sectional Survey Study. JMIR Medical Education. https://doi.org/10.2196/71767

Vancouver

Li A, Sheehan AH, Giuliano C, Dobry P, Walker P, Philips J, et al. Assessing Pharmacists’ Use and Perception of AI Chatbots in Pharmacy Practice: Cross-Sectional Survey Study. JMIR Medical Education. 2025. doi:10.2196/71767

BibTeX
@article{Li2025,
  author = {Li, Anly and Sheehan, Amy Heck and Giuliano, Christopher and Dobry, Paul and Walker, Paul and Philips, Jennifer and Jordan, Joseph},
  title = {Assessing Pharmacists’ Use and Perception of AI Chatbots in Pharmacy Practice: Cross-Sectional Survey Study},
  journal = {JMIR Medical Education},
  year = {2025},
  doi = {10.2196/71767}
}
Kostenlos starten →